Asset Allocation

As of August 31, 2025.
Type % Net
Cash 5.59%
Stock 61.67%
Bond 32.22%
Convertible 0.00%
Preferred 0.00%
Other 0.52%
View Asset Allocation
Start Trial

Market Capitalization

As of August 31, 2025
Large 86.22%
Mid 10.63%
Small 3.15%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.28%    % Emerging Markets: 0.07%    % Unidentified Markets: 0.64%

Americas 81.72%
81.23%
Canada 43.78%
United States 37.45%
0.48%
As of August 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 16.12%
United Kingdom 4.41%
10.65%
Belgium 1.12%
France 1.86%
Germany 3.18%
Ireland 1.80%
Italy 0.00%
Netherlands 1.36%
Switzerland 1.34%
0.00%
1.06%
Israel 1.00%
United Arab Emirates 0.06%
Greater Asia 1.52%
Japan 1.52%
0.00%
Australia 0.00%
0.00%
0.00%
Unidentified Region 0.64%

Bond Credit Quality Exposure

AAA 14.44%
AA 10.35%
A 18.90%
BBB 28.87%
BB 12.29%
B 7.35%
Below B 0.44%
    CCC 0.44%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.18%
Not Available 6.18%
Short Term 0.00%
As of August 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
24.14%
Materials
2.85%
Consumer Discretionary
4.38%
Financials
14.20%
Real Estate
2.72%
Sensitive
26.91%
Communication Services
3.10%
Energy
2.57%
Industrials
9.28%
Information Technology
11.96%
Defensive
12.31%
Consumer Staples
6.01%
Health Care
4.84%
Utilities
1.46%
Not Classified
36.64%
Non Classified Equity
0.38%
Not Classified - Non Equity
36.26%
As of August 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of August 31, 2025
Type % Net
Government 10.92%
Corporate 67.15%
Securitized 0.35%
Municipal 13.21%
Other 8.37%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.46%
Less than 1 Year
0.46%
Intermediate
68.98%
1 to 3 Years
9.06%
3 to 5 Years
20.07%
5 to 10 Years
39.84%
Long Term
28.52%
10 to 20 Years
5.06%
20 to 30 Years
12.23%
Over 30 Years
11.24%
Other
2.04%
As of August 31, 2025
View Bond Maturity Exposure
Start Trial